Y-mAbs Therapeutics, Inc.

NASDAQ:YMAB

13.57 (USD) • At close September 18, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q42017 Q1
Assets:
Current Assets:
Cash & Cash Equivalents 77.80675.74978.63786.57187.90992.629105.762114.526133.665156.724181.564215.73233.587252.271114.634131.267158.059185.774207.13698.192120.163134.245147.84163.29270.152-90.48390.483-16.875
Short Term Investments 0000000000000000000000000180.966033.75
Cash and Short Term Investments 77.80675.74978.63786.57187.90992.629105.762114.526133.665156.724181.564215.73233.587252.271114.634131.267158.059185.774207.13698.192120.163134.245147.84163.29270.15290.48390.48316.875
Net Receivables 38.21620.58822.45418.87419.11818.70212.5319.2517.2089.3247.7127.2648.5175.99700000000000000
Inventory 8.4988.4485.0657.1135.1878.9456.7026.2426.7945.5885.5124.7873.821.00500000000000000
Other Current Assets 2.2433.4824.9552.3023.573.735.4523.2256.2536.1037.4732.7993.4454.7367.7291.9425.2614.0624.8191.3993.0272.7593.6612.7211.54600.840
Total Current Assets 126.763108.267111.111114.86115.784124.006130.447133.244153.92177.739202.261230.58249.369264.009122.363133.209163.32189.836211.95599.591123.19137.034151.532166.04471.72990.48391.35516.875
Non-Current Assets:
Property, Plant & Equipment, Net 1.3581.3321.6361.8891.5531.882.3433.5413.9354.8525.6894.6485.3176.0746.3947.0113.6523.8574.0413.7752.6062.720.2050.1620.118000
Goodwill 0000000000000000000000000000
Intangible Assets 2.4542.5432.6312.722.8092.8982.9861.531.5741.6181.6631.81.81.800000000000000
Goodwill and Intangible Assets 2.4542.5432.6312.722.8092.8982.9861.531.5741.6181.6631.81.81.800000000000000
Long Term Investments 0000000000000000000000000000
Tax Assets 0000000000000000000000000000
Other Non-Current Assets 13.4611.17312.4919.41512.258.6615.685.65.7496.8383.172.9512.9933.0333.292.9750.3570.3810.370.3180.2440.2430.1870.1881.451-90.4830.772-16.875
Total Non-Current Assets 17.27215.04816.75814.02416.61213.43911.00910.67111.25813.30810.5229.39910.1110.9079.6849.9864.0094.2384.4114.0932.852.9630.3920.351.569-90.4830.772-16.875
Total Assets 144.035123.315127.869128.884132.396137.445141.456143.915165.178191.047212.783239.979259.479274.916132.047143.195167.329194.074216.366103.684126.04139.997151.924166.39473.298092.1270
Liabilities & Equity:
Current Liabilities:
Account Payables 10.196.7286.067.617.2528.84314.17513.72311.29114.66113.55211.0246.8036.5439.37210.329.82510.268.527.6288.9115.9075.8726.8274.24205.9090
Short Term Debt 0.8420.8880.9020.8980.8290.8550.8681.21.0921.4511.7831.8492.0141.9711.9661.8870.5690.5480.5160.5160.5020.517000000
Tax Payables 0000000000000000000000000000
Deferred Revenue 0-0.88800000000000000000003.36000000
Other Current Liabilities 32.43810.87713.16613.30416.15216.22213.24117.09217.06712.9312.5412.48612.1698.4868.1977.575.3134.0354.555.8484.2150.5173.2512.4891.48502.0160
Total Current Liabilities 43.4717.60520.12821.81224.23325.9228.28432.01529.4529.04227.87525.35920.9861719.53519.77715.70714.84313.58613.99213.62810.3019.1239.3165.72707.9250
Non-Current Liabilities:
Long Term Debt 0.4320.2930.5170.7250.4160.6290.8991.0191.3021.5981.8510.6540.9881.5152.0132.5171.3991.5431.7141.8211.982.133000000
Deferred Revenue Non-Current 0000000000000000000000000000
Deferred Tax Liabilities Non-Current 0000000000000000000000000000
Other Non-Current Liabilities 4.7976.2286.2396.1973.0663.0673.0522.9833.032.9352.9513.1213.1894.1844.6634.3894.2152.3582.1631.9322.052.052.2742.052.0502.050
Total Non-Current Liabilities 5.2296.5216.7566.9223.4823.6963.9514.0024.3324.5334.8023.7754.1775.6996.6766.9065.6143.9013.8773.7534.034.1832.2742.052.0502.050
Total Liabilities 48.69924.12626.88428.73427.71529.61632.23536.01733.78233.57532.67729.13425.16322.69926.21126.68321.32118.74417.46317.74517.65814.48411.39711.3667.77709.9750
Equity:
Preferred Stock 0000000000000000000000000000
Common Stock 0.0040.0040.0040.0040.0040.0040.0040.0040.0040.0040.0040.0040.0040.0040.0040.0040.0040.0040.0040.0030.0030.0030.0030.0030.00300.0030
Retained Earnings -473.348-464.099-457.47-456.482-448.735-442.433-436.043-437.2-409.674-368.543-340.475-303.582-274.724-251.787-285.2-265.267-232.435-192.042-165.863-142.727-118.805-100.769-84.835-70.775-59.3490-41.5610
Accumulated Other Comprehensive Income/Loss 1.0470.8480.4491.8491.0431.0251.3314.7023.1041.6821.3710.225-0.013-0.091-0.526-0.028-0.0160.0750.050.131-0.0030.0630.007-0.048-0.08882.152-0.16912.061
Other Total Stockholders Equity 567.633562.436558.002554.779552.369549.233543.929540.392537.962524.329519.206514.198509.049504.091391.558381.803378.455367.293364.712228.532227.187226.216225.352225.848124.9550123.8790
Total Shareholders Equity 95.33699.189100.985100.15104.681107.829109.221107.898131.396157.472180.106210.845234.316252.217105.836116.512146.008175.33198.90385.939108.382125.513140.527155.02865.52182.15282.15212.061
Total Equity 95.33699.189100.985100.15104.681107.829109.221107.898131.396157.472180.106210.845234.316252.217105.836116.512146.008175.33198.90385.939108.382125.513140.527155.02865.52182.15282.15212.061
Total Liabilities & Shareholders Equity 144.035123.315127.869128.884132.396137.445141.456143.915165.178191.047212.783239.979259.479274.916132.047143.195167.329194.074216.366103.684126.04139.997151.924166.39473.29882.15292.12712.061